China likely to approve BioNTech's Covid-19 vaccine by July - WSJ
If approved, it would become the first foreign Covid-19 vaccine to be authorised in the country
China is planning to authorise the Covid-19 vaccine developed by Germany's BioNTech SE by July, the Wall Street Journal reported on Friday, citing people familiar with the matter.
If approved, it would become the first foreign Covid-19 vaccine to be authorised in the country.
Chinese officials are reviewing clinical-trial data for the vaccine and are expected to authorize it for domestic use within the next 10 weeks, the report said.
Keep updated, follow The Business Standard's Google news channel
BioNTech did not immediately respond to a Reuters request for comment.
The German drugmaker announced a potential deal with Shanghai Fosun Pharmaceutical Group Co Ltd in August to supply 10 million doses of their Covid-19 vaccine to Hong Kong and Macau.
The vaccine, developed in collaboration with Pfizer Inc, is already approved in several countries, including the United States, the United Kingdom and Israel.
